By using a split-GFP tool, the translocated -Syn was found distributed at the OMM and IMS but not in the matrix
This triple mechanism distinguishes it from dual-agonist peptides like tirzepatide (GLP-1/GIP) and single-agonist compounds like semaglutide (GLP-1 only), making it the most broadly acting incretin-class compound currently under clinical investigation
Triple agonists add glucagon receptor activation, which: Increases resting energy expenditure by 8% to 12% (Jall et al., Diabetes Care 2024) Promotes hepatic fat oxidation and reduces steatosis May offset some of the lean mass loss seen with GLP-1 monotherapy (early signal, not yet confirmed in long-term trials) The weight loss ceiling for retatrutide appears to be 24% to 26% based on phase 3 data, though long-term real-world outcomes are not yet available
POWERFUL NUTRITIONAL BLEND - Featuring glutation, alpha lipoic acid, and milk thistle, these glutathione supplements work synergistically to ease oxidative stress, support liver health, and promote skin clarity while promoting overall well-being and natural energy levels